Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist

Nintedanib-induced diarrhoea may be controlled by ramosetron by modulation of intestinal motility as for irritable bowel syndrome #pulmonaryfibrosis https://bit.ly/3OQVAII

Detalles Bibliográficos
Autores principales: Arai, Toru, Inoue, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511131/
https://www.ncbi.nlm.nih.gov/pubmed/36171988
http://dx.doi.org/10.1183/23120541.00242-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511131/
https://www.ncbi.nlm.nih.gov/pubmed/36171988
http://dx.doi.org/10.1183/23120541.00242-2022

Ejemplares similares